Werkgroep Cardiologische centra Nederland English

ATLAS-1 (Klaar)

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Escalation and Dose-Confirmation Study to Evaluate the Safety and Efficacy of Rivaroxaban in Combination with Aspirin Alone or with Aspirin and a Thienopyridine in Subjects with Acute Coronary Syndromes

Middel
rivaroxaban
Populatie
acuut coronair syndroom
Fase
II
Jaar aanvang
2001
Meer informatie
ClinicalTrials.gov